Pharmabiz

Neuland appoints Saharsh Davuluri as CEO & MD to lead the next phase of CDMO expansion

Neuland appoints Saharsh Davuluri as CEO & MD to lead the next phase of CDMO expansion: Our Bureau, Bengaluru Thursday, April ...
Pharmabiz

Emcure Pharma reduces Poviztra starting dose price by 55% to expand patient access

Emcure Pharma reduces Poviztra starting dose price by 55% to expand patient access: Our Bureau, Mumbai Thursday, April 2, 2026, 17:15 Hrs [IST] Emcure Pharmaceuticals Ltd., a lead ...
Pharmabiz

Fortis Hospital Mulund hosts landmark 10th edition of ‘POCUS in Emergency Medicine’ Workshop, ahead of EMCON 2026

Fortis Hospital Mulund hosts landmark 10th edition of ‘POCUS in Emergency Medicine’ Workshop, ahead of EMCON 2026: Our Bureau ...
Pharmabiz

EMA consults on virtual control groups to help reduce animal use in medicines development

EMA consults on virtual control groups to help reduce animal use in medicines development: Amsterdam, The Netherlands Thursday, April 2, 2026, 17:00 Hrs [IST] EMA’s human medici ...
Pharmabiz

Bayer simplifies access to innovative eye care in India, enabling more patients to benefit from Eylea 2mg

Bayer simplifies access to innovative eye care in India, enabling more patients to benefit from Eylea 2mg: Our Bureau, Bengaluru Thursday, April 2, 2026, 16:15 Hrs [IST] Bayer is ...
Pharmabiz

Agenus begins patient enrolment in global phase 3 BATTMAN trial of BOT+BAL immunotherapy combination in MSS/pMMR metastatic colorectal cancer

Agenus begins patient enrolment in global phase 3 BATTMAN trial of BOT+BAL immunotherapy combination in MSS/pMMR metastatic colorectal cancer: Lexington, Massachusetts Thursday, A ...
Pharmabiz

Cardinal Health expands actinium-225 production capacity to support growing demand for novel cancer therapies

Cardinal Health expands actinium-225 production capacity to support growing demand for novel cancer therapies: Dublin, Ohio Thursday, April 2, 2026, 16:00 Hrs [IST] Cardinal Healt ...
Pharmabiz

Ministry of finance fully exempts customs duty on 40 chemicals

Ministry of finance fully exempts customs duty on 40 chemicals: Our Bureau, New Delhi Thursday, April 2, 2026, 15:30 Hrs [IST] The ministry of finance has fully exempted the custo ...
Pharmabiz

Nuvation Bio acquires Japanese rights to safusidenib from Daiichi Sankyo

Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer treatment, announced the company has amended its existing exclusive license agreement for ...
Pharmabiz

EU grants marketing approval to ALK’s EURneffy 1 mg, a needle-free adrenaline treatment for young children at risk of anaphylaxis

EU grants marketing approval to ALK’s EURneffy 1 mg, a needle-free adrenaline treatment for young children at risk of anaphylaxis: Denmark Thursday, April 2, 2026, 13:00 Hrs [IS ...
Pharmabiz

ZEISS India launches its ClearMind prescription lens for clear vision designed to reduce cognitive load

ZEISS India launches its ClearMind prescription lens for clear vision designed to reduce cognitive load: Our Bureau, Bengaluru Thursday, April 2, 2026, 12:30 Hrs [IST] ZEISS, a pi ...
Pharmabiz

Lupin completes acquisition of European specialty pharma company, VISUfarma

Lupin completes acquisition of European specialty pharma company, VISUfarma: Our Bureau, Mumbai Thursday, April 2, 2026, 13:45 Hrs [IST] Global pharma major Lupin Limited (Lupin) ...